| Literature DB >> 26060581 |
Tehmina Mustafa1, Karl Albert Brokstad2, Sayoki G Mfinanga3, Harald G Wiker4.
Abstract
Objectives. Tuberculous lymphadenitis is the most common form of extrapulmonary tuberculosis (TB) with a female and paediatric preponderance, postulated to be due to differences in the immune response. The aim of this study was to analyze the differences in the serum cytokine levels of tuberculous lymphadenitis patients with respect to age and gender. Methods. A multiplex bead-based enzyme-linked immunosorbent assay was used to measure IFN-γ, TNF-α, GM-CSF, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-15, and IL-17 levels in sera of patients (n = 86) and healthy controls (n = 23). Results. Levels of IFN-γ, TNF-α, GM-CSF, IL-1β, IL-2, IL-4, and IL-6 were higher in adult patients than in controls, while those of IL-12 were lower (P < 0.05). Children had lower levels of TNF-α, GM-CSF, and IL-5 and higher levels of IL-2 compared with adult patients (P < 0.05). The male adult patients had higher levels of IL-17 and lower levels of IL-12 compared with female adult patients (P < 0.05). Conclusion. There were significant differences in the levels of circulating cytokines with respect to gender and age. Children had generally lower levels of cytokines as compared to adults, which could make them more susceptible. Findings do not support that female preponderance is due to differences in immune response.Entities:
Year: 2015 PMID: 26060581 PMCID: PMC4427821 DOI: 10.1155/2015/561490
Source DB: PubMed Journal: Tuberc Res Treat ISSN: 2090-150X
The characteristics of the study population.
| Adults ( | Children ( | |
|---|---|---|
| Age in years | Median 28, range 16–75 | Median 9, range 2–14 |
| Males ( | 27 | 10 |
| Females ( | 34 | 15 |
| Culture positive ( | 13/61∗ | 3/23∗ |
| HIV positive ( | 5/44∗ | 0/12∗ |
| BCG vaccinated ( | 45/57∗ | 21/25∗ |
n = number of cases; ∗denominator denotes the number of cases where results were available.
Serum cytokine levels in the adult and paediatric patients with tuberculous lymphadenitis and healthy controls.
| Cytokine (pg/mL) | Adult patients ( | Healthy controls ( |
| Pediatric patients ( |
|
|---|---|---|---|---|---|
| IFN- | 0.0 (0–42.8) | 0.0 (0–1.5) | 0.001 | 0.0 (0–40.4) | 0.268 |
| TNF- | 8.4 (0–352.5) | 2.5 (0–51.7) | 0.005 | 3.2 (0–33.4) | 0.015 |
| GM-CSF | 35.2 (0–506.9) | 0.0 (0–379.2) | 0.007 | 0.0 (0–147.9) | 0.023 |
| IL-1 | 48.7 (0–6305.4) | 0.0 (0–933.2) | 0.004 | 4.0 (0–610.5) | 0.338 |
| IL-2 | 0.0 (0–28.2) | 0.3 (0–16.3) | 0.038 | 1.0 (0–105.6) | 0.003 |
| IL-4 | 0.0 (0–18.5) | 0.0 (0–4.3) | 0.002 | 0.0 (0–5.4) | 0.208 |
| IL-5 | 1.0 (0–10.0) | 0.5 (0–12.5) | 0.559 | 0.0 (0–1.5) | 0.001 |
| IL-6 | 47.4 (0–25781.5) | 0.0 (0–9355.1) | 0.000 | 44.1 (0–587.4) | 0.244 |
| IL-8 | 370.4 (0–386578.0) | 65.9 (1.6–2888.2) | 0.071 | 68.2 (0–3551.4) | 0.195 |
| IL-10 | 0.0 (0–29.3) | 0.0 (0–36.2) | 0.560 | 0.0 (0–9.9) | 0.233 |
| IL-12 | 0.0 (0–37.8) | 2.7 (0–15.3) | 0.000 | 0.0 (0–9.5) | 0.701 |
| IL-15 | 0.0 (0–61.4) | 0.0 (0–12.7) | 0.812 | 0.6 (0–53.3) | 0.385 |
| IL-17 | 0.0 (0–133.7) | 0 | 0.282 | 0 | 0.262 |
∗ P value for difference between adult patients and healthy controls and ∗∗ P value for difference between adult and pediatric patients.
Relationship between the serum levels of cytokines in adult patients with tuberculous lymphadenitis (n = 61) based on Spearman's rank correlation. The values shown are the correlation coefficients.
| TNF- | GM-CSF | IL-1 | IL-2 | IL-4 | IL-5 | IL-6 | IL-8 | IL-10 | IL-12 | IL-15 | IL-17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IFN- | .729∗∗ | .741∗∗ | .723∗∗ | .058 | .018 | .252∗ | .732∗∗ | .551∗∗ | .335∗∗ | −.193 | −.025 | .178 |
| TNF- | .828∗∗ | .724∗∗ | .081 | .055 | .217 | .674∗∗ | .577∗∗ | .315∗ | −.035 | .119 | −.103 | |
| GM-CSF | .723∗∗ | .062 | −.012 | .230 | .794∗∗ | .651∗∗ | .210 | −.063 | .075 | −.051 | ||
| IL-1 | .213 | .312∗ | .287∗ | .687∗∗ | .539∗∗ | .275∗ | −.109 | .208 | .154 | |||
| IL-2 | .150 | .275∗ | .076 | −.028 | .181 | .183 | .454∗∗ | .086 | ||||
| IL-4 | .061 | −.012 | .068 | .034 | −.207 | .037 | .251 | |||||
| IL-5 | .138 | .261∗ | .241 | .022 | .188 | −.134 | ||||||
| IL-6 | .597∗∗ | .066 | −.038 | −.050 | .050 | |||||||
| IL-8 | .123 | −.011 | −.057 | .076 | ||||||||
| IL-10 | −.043 | .068 | .218 | |||||||||
| IL-12 | .459∗∗ | −.171 | ||||||||||
| IL-15 | .011 |
∗∗Correlation is significant at the 0.01 level (2-tailed). ∗Correlation is significant at the 0.05 level (2-tailed).
Relationship between the serum levels of cytokines in children with tuberculous lymphadenitis (n = 25) based on Spearman's rank correlation. The values shown are the correlation coefficients.
| TNF- | GM-CSF | IL-1 | IL-2 | IL-4 | IL-5 | IL-6 | IL-8 | IL-10 | IL-12 | IL-15 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IFN- | .566∗∗ | .716∗∗ | .369 | −.244 | .389 | .274 | .440∗ | .497∗ | .151 | −.200 | −.111 |
| TNF- | .802∗∗ | .611∗∗ | .028 | .213 | .303 | .528∗∗ | .648∗∗ | .108 | −.047 | .291 | |
| GM-CSF | .726∗∗ | .039 | .442∗ | .527∗∗ | .758∗∗ | .875∗∗ | .026 | −.191 | .154 | ||
| IL-1 | .336 | .490∗ | .646∗∗ | .596∗∗ | .671∗∗ | −.176 | −.114 | .424∗ | |||
| IL-2 | −.226 | −.039 | .122 | .150 | −.133 | .256 | .448∗ | ||||
| IL-4 | .745∗∗ | .341 | .376 | .008 | −.391 | −.076 | |||||
| IL-5 | .401∗ | .469∗ | .070 | −.538∗∗ | −.038 | ||||||
| IL-6 | .842∗∗ | −.190 | −.282 | .072 | |||||||
| IL-8 | −.068 | −.115 | .194 | ||||||||
| IL-10 | −.259 | −.474∗ | |||||||||
| IL-12 | .530∗∗ |
∗∗Correlation is significant at the 0.01 level (2-tailed). ∗Correlation is significant at the 0.05 level (2-tailed).
Differences in the serum cytokine levels in the adult Tanzanian patients based on gender and mycobacterial culture from lymph nodes.
| Cytokine (pg/mL) | Male ( | Female ( |
| Culture positive ( | Culture negative ( |
|
|---|---|---|---|---|---|---|
| IFN- | 0.0 (0–42.8) | 0.0 (0–30.9) | 0.98 | 0.0 (0–22.4) | 0.0 (0–42.8) | 0.383 |
| TNF- | 3.2 (0–352.5) | 11.8 (0–73) | 0.15 | 8.4 (0.5–352.5) | 12.4 (0–72.9) | 0.874 |
| GM-CSF | 35.2 (0–507) | 55.1 (0–457) | 0.96 | 35.2 (0–506.9) | 34.5 (0–457.7) | 0.864 |
| IL-1 | 72.6 (0–1338) | 5.7 (0–6305) | 0.51 | 0.0 (0–1338.8) | 66.5 (0–6305.4) | 0.746 |
| IL-2 | 0.0 (0–28) | 0.0 (0–19.8) | 0.31 | 0.0 (0–28.2) | 0.0 (0–19.8) | 0.193 |
| IL-4 | 0 (0–9.5) | 0 (0–18) | 0.30 | 0.0 (0–6.8) | 0.0 (0–18.5) | 0.360 |
| IL-5 | 1.5 (0–10) | 0.75 (0–6.4) | 0.16 | 1.0 (0–8.1) | 1.0 (0–10.0) | 0.465 |
| IL-6 | 46.4 (0–18979) | 55.5 (0–25781) | 0.80 | 46.4 (0–18979.1) | 55.6 (0–25781.5) | 0.825 |
| IL-8 | 362 (0–27670) | 419 (0–386577) | 0.70 | 638.2 (0–27670.3) | 366.4 (0–386578.0) | 0.486 |
| IL-10 | 0.0 (0–29) | 0.0 (0–22) | 0.96 | 0.0 (0–29.3) | 0.0 (0–22.8) | 0.513 |
| IL-12 | 0 (0–20.7) | 0.1 (0–37) | 0.03 | 0.3 (0–20.7) | 0.0 (0–37.8) | 0.029 |
| IL-15 | 0.0 (0–61) | 0.0 (0–25) | 0.77 | 0.6 (0–21.1) | 0.0 (0–61.4) | 0.223 |
| IL-17 | 0 (0–134) | 0 | 0.04 | 0.0 (0–26.1) | 0.0 (0–133.7) | 0.638 |
∗ P value for difference between males and females and ∗∗ P value for difference between culture positive and culture negative TB patients.